HPV16 DNA Methylation and Cervical Cancer Risk
Author Information
Author(s): Xi Long Fu, Jiang Mingjun, Shen Zhenping, Hulbert Ayaka, Zhou Xiao-Hua, Lin Ying-Ying, Kiviat Nancy B., Koutsky Laura A.
Primary Institution: University of Washington
Hypothesis
Is there an association between the methylation of HPV16 DNA and the risk of developing cervical intraepithelial neoplasia grades 2 or 3 (CIN2/3)?
Conclusion
The degree of HPV16 DNA methylation is inversely related to the risk of developing CIN2/3.
Supporting Evidence
- CIN2/3 was confirmed in 44.5% of the HPV16 positive women studied.
- The likelihood of CIN2/3 diagnosis increased with fewer methylated CpGs.
- Women with ≥4 meCpGs had a significantly lower risk of CIN2/3.
- The association remained significant after adjusting for various factors.
- Current smokers showed a more substantial risk reduction related to methylation.
Takeaway
Women with more methylated HPV16 DNA are less likely to develop serious cervical problems. It's like having a shield that protects you from getting sick.
Methodology
The study analyzed HPV16 DNA methylation in cervical samples from women attending routine screenings, using logistic regression to assess the association with CIN2/3.
Potential Biases
Potential bias due to the mixed cell population in cervical swabs and the small sample size for certain subgroups.
Limitations
The study had a small number of cases with high methylation among current smokers, and the sample reflects a mixed population of cells.
Participant Demographics
Women aged 18-50, HPV16 positive, attending Planned Parenthood clinics in Western Washington.
Statistical Information
P-Value
0.003
Confidence Interval
0.12–0.79
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website